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Introduction {#sec1}
============

The early embryonic development of many animals, particularly those that develop externally, involves a rapid expansion in cell numbers. These fast early cell divisions exhibit very little zygotic transcription and rely on maternally supplied products ([@bib24], [@bib42]). After a species-specific number of rapid divisions, the cell cycle elongates and the zygotic transcriptional program is established. This developmental event is called the mid-blastula transition (MBT) or the maternal to zygotic transition (MZT; [@bib42]). The MBT is also the point when many additional cellular processes are coordinated, including the onset of cell-cycle checkpoints, apoptosis, and cell motility ([@bib6], [@bib13], [@bib19], [@bib30], [@bib31]). How the events of the MBT are timed and coordinated is poorly understood, yet these processes are critical for subsequent gastrulation when the three germ layers of the embryo are formed.

One mechanism responsible for timing the events of the MBT involves the nuclear to cytoplasmic (N/C) ratio ([@bib8], [@bib19], [@bib30]). In the virtual absence of growth and zygotic transcription, the early cell-cleavage divisions result in an exponential increase in the ratio of DNA to cytoplasm. The N/C ratio has been proposed to act as a timing mechanism by switching on cellular responses when particular maternally deposited components become critically limiting. Such an N/C ratio timer has been shown in frog, fish, and fly embryos to be responsible for coordinating cell-cycle changes, checkpoint activation, and the transcription of subsets of zygotic genes ([@bib8], [@bib10], [@bib19], [@bib30]). The N/C ratio is not the only timer required to trigger the MBT, as several events occur independently of DNA content including the degradation of maternal mRNA ([@bib42]) and the downregulation of cyclin E in *Xenopus* ([@bib15]).

The lengthening of the cell cycle at the MBT in flies and frogs coincides with changes in DNA replication dynamics and decreased rates of replication initiation ([@bib17], [@bib36]). We have shown in *Xenopus laevis* embryos that the increasing N/C ratio titrates out four replication initiation factors Drf1, Treslin, Recq4, and Cut5 ([@bib5]). Over-expression of these factors in *Xenopus* embryos sustains high rates of replication initiation, which is sufficient to allow the continuation of rapid cleavage divisions after the MBT at least during cycles 12--15 ([@bib5]). Importantly the number of rapid cleavage divisions induced by these factors after the MBT is closely linked to their protein levels, supporting the idea that titration of these chromatin binding factors by the increasing N/C ratio acts as a timer governing cell-cycle duration ([@bib5]). For the cell cycle to lengthen after precisely the correct number of cycles, the amounts of these four factors must therefore be strictly controlled during early embryogenesis, but how this is achieved is not clear.

One of the events of the MBT is the activation of the checkpoint kinase Chk1 ([@bib37], [@bib38]), which is essential for early embryogenesis across metazoa ([@bib9], [@bib18], [@bib25], [@bib37], [@bib44]). Interestingly, over-expression of Drf1, Treslin, Recq4, and Cut5, which causes rapid cell cycles at the MBT, also leads to increased and premature Chk1 activation, due in part to depletion of deoxynucleotide triphosphate pools ([@bib5]). In other systems such as in mammalian cells, Chk1 is known to inhibit cell-cycle progression either by blocking entry into mitosis through regulation of CDK activity ([@bib1]) or by inhibiting DNA replication ([@bib26]). We therefore set out to understand how *X. laevis* embryos over-expressing limiting replication factors have fast cell cycles at the MBT even though Chk1 is active.

Our results show that Chk1 regulates the abundance of the replication factor Drf1 at the MBT through phospho-dependent degradation by the SCF^β-TRCP^ E3 ubiquitin ligase. Through manipulation of both Chk1 and SCF^β-TRCP^ activities we demonstrate that this pathway guarantees the lengthening of the cell cycle by ensuring that Drf1 levels become critically limiting at the correct stage of development. Inhibition of Drf1 is the primary mechanism by which Chk1 inhibits the cell cycle in the early embryo, and we show that this is an essential function for Chk1 during blastula-to-gastrula stages. Together, the results of this study uncover a mechanism to ensure that the egg is subdivided into the exact number of cells during normal embryogenesis and provide insight into how events at the MBT are coordinated.

Results {#sec2}
=======

Chk1 Inhibition Alone Does Not Affect the Cell Cycle at the MBT {#sec2.1}
---------------------------------------------------------------

In normal *X. laevis* embryos developing at 20°C, the MBT occurs at 6.5--7.5 hr post fertilization. This event is marked by the transient developmental phosphorylation and activation of the checkpoint kinase Chk1 ([@bib37]; [Figure 1](#fig1){ref-type="fig"}A). We have previously shown that over-expression of the limiting replication initiation factors Drf1, Treslin, Recq4, and Cut5, which causes continuation of rapid, synchronous cleavage divisions during the MBT, leads to earlier and increased Chk1 activation ([Figure 1](#fig1){ref-type="fig"}A; [@bib5]). Since embryos over-expressing limiting replication factors have fast cell cycles at the MBT despite earlier Chk1 activation, we wondered what role Chk1 might play in controlling the embryonic cell cycle.Figure 1Chk1 Inhibition Does Not Affect the Cell Cycles at the MBT(A) Western blot of Chk1 and β-actin from staged embryos at the indicated number of hours post fertilization (hrs.p.f). Embryos were injected at the one cell stage either with water (control) or with mRNA of the four limiting replication factors (*treslin*, *drf1*, *recq4*, and *cut5*) or the *chk1* dominant-negative mutant (D148A). The extracts from embryos over-expressing Chk1 D148A were diluted 1 in 20 to allow a direct comparison between endogenous and over-expressed Chk1. See also [Figure S1](#mmc1){ref-type="supplementary-material"}A.(B) Still images from time-lapse movies of embryos injected in both blastomeres at the 2-cell stage as in (A) The fourth division, generating the 16-cell embryo, was set to time zero. See also [Movie S1](#mmc2){ref-type="supplementary-material"}.(C) The division of embryonic cells from (B) were followed throughout the movie. Each time point represents the division of a single cell. The cell divisions for the three conditions are displayed side by side for each cleavage cycle. Cleavages 4--7 are excluded for simplicity. n = 16 cells from four embryos for each condition.(D) Total number of divisions undergone by each cell in (C) until the end of the time-lapse movie.(E) The DNA content of embryos, injected as in (A), was quantified on agarose gels using ImageJ. The DNA content of control embryos was set to 1. Data are presented as mean ± SD, n = 5. See also [Figure S1](#mmc1){ref-type="supplementary-material"}B.

To test the role of Chk1 in the early embryonic divisions in *X. laevis*, we over-expressed a dominant-negative, kinase-dead mutant of *chk1* (D148A, [@bib37]) by injection of mRNA into 1-cell embryos. Over-expression of this mutant abrogates the phosphorylation of Chk1 targets including Cdc25 ([@bib46]) and itself ([Figure S1](#mmc1){ref-type="supplementary-material"}A) and as a result this Chk1 D148A mutant did not exhibit an activation-dependent mobility shift at the MBT ([Figure 1](#fig1){ref-type="fig"}A). To assess the effects of Chk1 inhibition on the cell cycle, we analyzed movies of embryos over-expressing this kinase-dead mutant ([Movie S1](#mmc2){ref-type="supplementary-material"} and [Figure 1](#fig1){ref-type="fig"}B). To quantify these movies and standardize our analyses between embryos, we set the fourth cleavage (16-cell embryo) to time zero and followed the timing of division of individual blastomeres ([Figure 1](#fig1){ref-type="fig"}C). In addition, we measured the total number of cleavages undergone by each blastomere throughout the length of the movie ([Figure 1](#fig1){ref-type="fig"}D). Together, these data provide the timing and frequency of division of cells in live embryos.

While the cell cycles in control embryos slowed at the MBT after cleavage 12 (green crosses, [Figure 1](#fig1){ref-type="fig"}C), over-expression of limiting replication factors caused an increased number of synchronous cleavages at the MBT ([Figures 1](#fig1){ref-type="fig"}C and 1D), as expected ([@bib5]). As a result, post-MBT embryos that over-express these limiting factors have more cells, which are smaller in size than in control embryos ([Figure 1](#fig1){ref-type="fig"}B). By contrast, over-expression of the kinase-dead *chk1* had little effect on cell-cycle duration or the total number of divisions, and these embryos resembled controls after the MBT ([Figures 1](#fig1){ref-type="fig"}B--1D). A previous study using the same *chk1 D148A* allele inferred that Chk1 inhibition was sufficient to allow extra cell divisions after the MBT through measurement of the DNA content of the embryo ([@bib37]). To explore this discrepancy, we analyzed the DNA content of embryos post MBT ([Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}B). Consistent with our cytological analyses, embryos over-expressing limiting replication initiation factors, which have approximately doubled their cell numbers relative to controls 1 hr post MBT ([Figure 1](#fig1){ref-type="fig"}C), had also doubled their DNA content, whereas Chk1 D184A over-expressing embryos had not ([Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}B). From this we conclude that Chk1 inhibition alone has little effect on the cell cycle at the MBT in *X. laevis*. We are not sure why a previous study ([@bib37]) reached a different conclusion using the same *chk1* allele at similar levels of over-expression.

Since Chk1 inhibition does not affect the elongation of the cell cycle in *Xenopus*, at least during cycles 12--15 ([Figure 1](#fig1){ref-type="fig"}), we wondered whether Chk1 activity regulates the cell cycle at all in this organism. In line with previous studies ([@bib21]), over-expressed wild-type *chk1* was active in the early embryo and robustly inhibited cell-cycle progression ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). We therefore set out to reconcile how embryos over-expressing limiting replication factors have fast cell cycles even though Chk1 has even higher than normal levels of activation ([Figure 1](#fig1){ref-type="fig"}A).

Chk1 Inhibits the Limiting Replication Factor Drf1 at the MBT {#sec2.2}
-------------------------------------------------------------

We have previously shown that Rad53, the functionally analogous kinase to Chk1 in budding yeast, blocks S-phase progression by inhibiting two replication initiation factors, Dbf4 and Sld3 ([@bib48]). *Xenopus* Treslin is orthologous to yeast Sld3 ([@bib22]) and there are two *Xenopus* orthologs of Dbf4 (Dbf4 and Drf1), with Drf1 being predominant during cleavage divisions ([@bib39], [@bib43]). Since both Drf1 and Treslin are limiting replication initiation factors at the MBT in *X. laevis* ([@bib5]), we wondered whether the normal function of Chk1 is to inhibit one or more of these limiting factors and that by over-expressing them we effectively bypass Chk1 function.

To test whether *Xenopus* Chk1 regulates Drf1, Dbf4 or Treslin, we analyzed the phosphorylation of these proteins at the MBT in the presence or absence of active Chk1. While we did not detect any Chk1-dependent modifications of Treslin or Dbf4 ([Figure 2](#fig2){ref-type="fig"}A and data not shown), we did observe that Drf1 abundance decreased dramatically after the MBT in *Xenopus* as previously described ([@bib39], [@bib43]). Significantly, this downregulation of Drf1 was coincident with Chk1 activation and was dependent on Chk1 activity ([Figure 2](#fig2){ref-type="fig"}A).Figure 2Chk1 Inhibits Drf1 at the MBT(A) Western blot as in [Figure 1](#fig1){ref-type="fig"}A. For only the Chk1 blot from the over-expression of *chk1 D148A*, extracts were diluted 1 in 20 to allow a direct comparison between endogenous and over-expressed Chk1. All other samples are undiluted.(B--D) As for [Figures 1](#fig1){ref-type="fig"}B--1D. For (C) and (D), n = 15 cells from four embryos for each condition.See also [Movies S2](#mmc3){ref-type="supplementary-material"} and [S3](#mmc4){ref-type="supplementary-material"}; [Figure S2](#mmc1){ref-type="supplementary-material"}.

If a role for Chk1 at the MBT is to limit Drf1 abundance, then we hypothesized that inhibition of Chk1 together with over-expression of the other three limiting factors, Cut5, Treslin, and Recq4, should permit the continuation of fast cell cycles at the MBT. As we have shown previously ([@bib5]), over-expression of Cut5, Treslin, and Recq4 without Drf1 is not sufficient to drive fast cleavage divisions beyond the MBT, and these embryos resembled controls ([Movie S2](#mmc3){ref-type="supplementary-material"} and [Figures 2](#fig2){ref-type="fig"}B--2D). Importantly, however, when we combined over-expression of Chk1 D148A with over-expression of Cut5, Treslin, and Recq4, embryos underwent at least one extra division after the MBT, resulting in embryos with a greater number of smaller cells ([Figures 2](#fig2){ref-type="fig"}B--2D). From this we conclude that Chk1 is an inhibitor of Drf1 and that in the absence of Chk1 activation, Drf1 levels are sufficient for rapid S-phase progression at least during cycle 13 if the other three limiting replication factors are abundant.

Although our analyses in [Figure 2](#fig2){ref-type="fig"}A did not identify other potential targets of Chk1, it is feasible that developmental Chk1 activation leads to the inhibition of other replication factors, such as Treslin. If this were the case then we would expect that Chk1 inhibition would prevent such a factor becoming limiting at the MBT, as observed with Drf1 ([Figures 2](#fig2){ref-type="fig"}B--2D). To test this we over-expressed all combinations of just two of the limiting factors in embryos expressing Chk1 D148A. As shown in [Movie S3](#mmc4){ref-type="supplementary-material"} and [Figure S2](#mmc1){ref-type="supplementary-material"}, only when Treslin, Recq4, and Cut5 were all over-expressed together with Chk1 D148A did extra divisions continue beyond the MBT. From this we conclude that Chk1 inhibits Drf1, but not the other three limiting factors at the MBT.

Chk1 Blocks Cell-Cycle Progression by Inhibition of DDK {#sec2.3}
-------------------------------------------------------

Drf1 and Dbf4 bind to and activate Cdc7, to form the DDK (Dbf4-dependent kinase) complex, which is required for replication initiation ([@bib23]). In pre-MBT embryos Drf1-Cdc7 is the predominant form of DDK, while after the MBT Drf1 is replaced by Dbf4 ([@bib39], [@bib43]). Both Drf1-Cdc7 and Dbf4-Cdc7 facilitate the essential role of DDK in replication initiation ([@bib39], [@bib43]) and either Drf1 or Dbf4 over-expression, together with the other three limiting replication factors, can support fast cell cycles during the MBT (data not shown). These paralogs are therefore equivalent for their essential roles in replication initiation, yet are differently regulated by Chk1 ([Figure 2](#fig2){ref-type="fig"}A).

As Chk1 regulates Drf1 levels ([Figure 2](#fig2){ref-type="fig"}A) and premature Chk1 activation inhibits the cell cycle in pre-MBT embryos ([Figure S1](#mmc1){ref-type="supplementary-material"}D; [@bib21]), we wondered whether this Chk1-mediated cell-cycle control might occur through inhibition of Drf1. To address this question we over-expressed wild-type *chk1* together with either *dbf4* or *drf1*. Over-expression of wild-type *chk1* resulted in cell-cycle arrest as expected ([Figure 3](#fig3){ref-type="fig"}A), but importantly this arrest was rescued by co-over-expression of Dbf4 and partially rescued by over-expression of Drf1 ([Figure 3](#fig3){ref-type="fig"}A).Figure 3Chk1 Blocks the Cell Cycle by Inhibiting DDK(A) Images of pre-MBT embryos (6 hr post fertilization), not expressing (Control) or expressing increasing amounts of *chk1* mRNA (pg), with or without co-expression of 500 pg of *drf1* or *dbf4*. See also [Figures S1](#mmc1){ref-type="supplementary-material"}C--S1E.(B) Analysis of the division of individual cells, as in [Figure 1](#fig1){ref-type="fig"}C, from movies of embryos expressing 50 pg of *chk1* mRNA, with or without co-expression of 500 pg of *drf1* or *dbf4*. The second division, generating the 4-cell embryo, was set to time zero. n = 12 cells from three embryos for each condition. See also [Movie S5](#mmc6){ref-type="supplementary-material"}.(C) The average duration of cell cycle 5, generating the 32-cell embryo. Red dashed line shows mean time of cycle 5 for control embryos. n = 12 cells from three embryos for each condition. Data are presented as mean ± SD, which indicates the level of synchrony of cell division. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

To analyze this in more detail, we timed individual cleavage divisions in embryos. Chk1 over-expression greatly increased the length and asynchrony of cell divisions in the early embryo ([Figure 3](#fig3){ref-type="fig"}B \[blue diamonds\] and [Movie S5](#mmc6){ref-type="supplementary-material"}). Both Drf1 and Dbf4 over-expression rescued the Chk1-dependent block to cell-cycle progression, resulting in shorter cycles with greater synchrony ([Figure 3](#fig3){ref-type="fig"}B). As in [Figure 3](#fig3){ref-type="fig"}A, Dbf4 was a better suppressor of Chk1-mediated cell-cycle arrest than Drf1 ([Figure 3](#fig3){ref-type="fig"}B). We presume that the difference in effectiveness between Dbf4 and Drf1 in rescuing the Chk1-mediated cell-cycle defect is due to the fact that Drf1 is inhibited by Chk1 while Dbf4 is not ([Figure 2](#fig2){ref-type="fig"}A and [Discussion](#sec3){ref-type="sec"}). By quantifying a single cleavage cycle (cycle 5) across multiple embryos, it is clear that Dbf4 over-expression is sufficient to return the cell-cycle duration ([Figure 3](#fig3){ref-type="fig"}C, red dotted line) and the synchrony of division ([Figure 3](#fig3){ref-type="fig"}C, error bars) back to wild-type levels after Chk1 over-expression. This rescue of ectopic Chk1 activation by Drf1 or Dbf4 is not because DDK is acting as an inhibitor of Chk1, as over-expression of Drf1 or Dbf4 does not inhibit Chk1 activity in *Xenopus* embryos ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}E). The ability of Drf1 over-expression to bypass the Chk1-mediated cell-cycle inhibition likely explains how over-expression of the four limiting factors (including Drf1) is sufficient to allow fast cell cycles at the MBT regardless of Chk1 activation levels ([Figure 1](#fig1){ref-type="fig"}).

Drf1 and Dbf4 have equivalent roles in DNA replication as part of DDK, and both can rescue the cell-cycle arrest caused by Chk1 over-expression ([Figure 3](#fig3){ref-type="fig"}). These data therefore suggest that Chk1 blocks the cell cycle by inhibiting replication initiation through inhibition of DDK. Indeed, *Xenopus* Chk1 has been shown to be an inhibitor of DNA replication *in vitro* ([@bib34]). Despite this, previous studies involving soaking embryos in replication inhibitors suggested that inhibition of DNA replication could not prevent cell-cycle progression before the MBT in *Xenopus* ([@bib29]). However, as shown in [Figure S3](#mmc1){ref-type="supplementary-material"}, injection of the replication inhibitor aphidicolin into *Xenopus* embryos resulted in a robust block to cell-cycle progression. We therefore conclude that inhibition of DNA replication is sufficient to block cell-cycle progression in early *Xenopus* embryos. We suggest that the earlier studies ([@bib29]) may be misleading because the tight cell-cell junctions in pre-MBT embryos prevent the effective uptake of inhibitors from the surrounding media.

Inhibitory Phosphorylation of Cdk1 Is Not Important for Cell-Cycle Lengthening at the MBT in *Xenopus* {#sec2.4}
------------------------------------------------------------------------------------------------------

In many organisms Chk1 inhibits cell-cycle progression by promoting the inhibitory phosphorylation of Cdk1, either by inactivating Cdc25 or activating Wee1 ([@bib47]). Indeed, this is an important mechanism that controls cell-cycle length during the MBT in *Drosophila* ([@bib47]). Since over-expression of Drf1 or Dbf4 is sufficient to suppress the cell-cycle delay caused by ectopic Chk1 expression ([Figure 3](#fig3){ref-type="fig"}C), we wondered whether the inhibitory phosphorylation of Cdk1 (also called Cdc2 in *Xenopus*) plays any role in Chk1-mediated control of cell-cycle progression in *Xenopus*. To explore this, we used a mutant of Cdk1 (*cdk1-AF*) that cannot be inhibited by Wee1/Myt1 phosphorylation because the inhibitory phosphorylation sites threonine 14 and tyrosine 15 are mutated to alanine and phenylalanine, respectively ([@bib33]). In contrast to Dbf4/Drf1 over-expression ([Figure 3](#fig3){ref-type="fig"}C), the *cdk1-AF* mutant had no effect on the Chk1-dependent block to cell-cycle progression ([Figure S4](#mmc1){ref-type="supplementary-material"}). This observation is consistent with the inhibition of DDK being the primary mechanism for Chk1-mediated control of cell-cycle progression in the early *Xenopus* embryo ([Figure 3](#fig3){ref-type="fig"}).

Although Cdk1-AF over-expression could not suppress ectopic Chk1 activation, we wondered whether inhibitory phosphorylation of Cdk1 influences the elongation of the cell cycle at the MBT. Over-expression of *cdk1-AF* had no effect on cell-cycle lengthening during the MBT in *Xenopus* embryos ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5C). Since one of the functions of Chk1 is to ensure the downregulation of Drf1, which is limiting at the MBT ([Figure 2](#fig2){ref-type="fig"}), *cdk1-AF* over-expression alone may not be sufficient to sustain rapid divisions at the MBT. Despite this, additional over-expression of Drf1 together with *cdk1-AF* still did not affect cell-cycle lengthening at the MBT ([Figures S5](#mmc1){ref-type="supplementary-material"}D--S5F). Thus we find no evidence for a role for inhibitory phosphorylation of Cdk1 in regulating cell-cycle changes at the MBT in *X. laevis* (see [Discussion](#sec3){ref-type="sec"}).

SCF^β-TRCP^ Regulates Drf1 Levels at the MBT {#sec2.5}
--------------------------------------------

Given the significance of the Chk1-dependent downregulation of Drf1 at the MBT for control of the cell cycle ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}), we set out to determine the mechanism for this regulation. Previous studies in *Xenopus* embryos have shown that Chk1 mediates the degradation of the CDK-activating phosphatase Cdc25A after the MBT ([@bib37]) and that this requires the E3 ubiquitin ligase SCF^β-TRCP^ ([@bib20]). We therefore wondered whether a similar pathway might be responsible for the degradation of Drf1 at the MBT.

To test a role for SCF^β-TRCP^ in Drf1 degradation, we modified the levels of the critical substrate recognition subunit β-Trcp in *Xenopus* embryos and analyzed the stability of Drf1 at the MBT. Injection of an anti-*β-trcp* antisense morpholino oligonucleotide reduced the levels of endogenous β-Trcp ([Figure 4](#fig4){ref-type="fig"}A, right) and resulted in the stabilization of Drf1 at the MBT ([Figure 4](#fig4){ref-type="fig"}A, left). Conversely, over-expression of β-Trcp caused even more rapid degradation of Drf1 ([Figure 4](#fig4){ref-type="fig"}B). Together these results suggest that, as with Cdc25, SCF^β-TRCP^ regulates Drf1 at the MBT in *Xenopus*.Figure 4β-TRCP Controls Drf1 Levels(A and B) Western blots as in [Figure 2](#fig2){ref-type="fig"}A (left for Drf1/Dbf4, right for β-TRCP at 8 hrs.p.f). For (A) the control was injection of a control morpholino. Asterisk denotes non-specific band.(C--E) As for [Figures 1](#fig1){ref-type="fig"}B--1D. For (C) and (D), n = 20 cells from five embryos for each condition. MO, morpholino.See also [Movie S4](#mmc5){ref-type="supplementary-material"} and [Figure S6](#mmc1){ref-type="supplementary-material"}.

Stabilization of Drf1 (through inhibition of Chk1) delays it becoming limiting for S-phase progression at the MBT ([Figure 2](#fig2){ref-type="fig"}). To test the importance of SCF^β-TRCP^-dependent degradation of Drf1 in ensuring that the cell cycle elongates at the MBT, we wondered whether over-expression of the other three limiting replication factors together with a reduction in SCF^β-TRCP^ activity would be sufficient to drive fast cell cycles at the MBT. On its own, downregulation of *β-trcp* did not affect cell-cycle progression at the MBT ([Movie S4](#mmc5){ref-type="supplementary-material"} and [Figures 4](#fig4){ref-type="fig"}C--4E), and these embryos resembled the controls. However, when we over-expressed the remaining limiting replication factors, Treslin, Recq4, and Cut5, together with the *β-trcp* morpholino, this resulted in an extra division after the MBT ([Figures 4](#fig4){ref-type="fig"}D and 4E), generating embryos with more and smaller cells ([Figure 4](#fig4){ref-type="fig"}C). Conversely, when we over-expressed β-Trcp to induce earlier Drf1 degradation, we observed that the cell cycle was prematurely elongated ([Figure S6](#mmc1){ref-type="supplementary-material"}). Together these results show that SCF^β-TRCP^ regulates the levels of a critical limiting replication factor, Drf1, which can control cell-cycle duration in the early *Xenopus* embryo.

We have previously shown that Drf1, together with Cut5, Treslin and Recq4, are out-titrated on chromatin by increasing N/C ratios *in vitro*. Since Chk1 and SCF^β-TRCP^ regulate Drf1 levels at the MBT *in vivo*, we wondered whether it is this pathway or the out-titration of Drf1 that causes this protein to become limiting at the MBT *in vivo*. By directly comparing SCF^β-TRCP^ inhibition with Drf1 over-expression, we observed that stabilization of Drf1 levels, together with the over-expression of Cut5, Treslin, and Recq4, while sufficient for an extra division at the MBT, was not sufficient to reduce cell-cycle asynchrony during the MBT cycles 12 or 13 ([Figure S7](#mmc1){ref-type="supplementary-material"}). On the other hand, over-expression of Drf1 plus the other three factors not only facilitated extra divisions but also caused these divisions to be rapid and synchronous ([Figure S7](#mmc1){ref-type="supplementary-material"}). From this we conclude that stabilization of Drf1 at the MBT does not result in sufficient levels of Drf1 to overcome the increasing N/C ratio. Instead our data are consistent with a role for Drf1 degradation as a guarantee that the cell cycle elongates on time by ensuring that the levels of this protein are sufficiently low to be out-titrated by the increasing N/C ratio (see [Discussion](#sec3){ref-type="sec"}).

Chk1 Phosphorylates Drf1 for β-Trcp-Dependent Degradation {#sec2.6}
---------------------------------------------------------

Since Chk1 and SCF^β-TRCP^ both regulate Drf1 levels at the MBT *in vivo* ([Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}), we set out to test how these pathways are connected. For Cdc25, Chk1-dependent phosphorylation of this protein generates a binding site for β-Trcp (which is an F-box protein), resulting in Cdc25 degradation ([@bib20]). To address whether there is a similar phospho-dependent interaction between Drf1 and β-Trcp, we expressed tagged versions of both proteins in *Xenopus* embryos and analyzed their interaction in MBT-stage extracts by co-immunoprecipitation. Drf1, but not an unrelated protein of the same size (Smicl), immunoprecipitated β-Trcp from MBT-stage embryos ([Figure 5](#fig5){ref-type="fig"}A). Addition of a phosphatase to the extracts greatly reduced binding between Drf1 and β-Trcp, suggesting that this interaction is phospho-dependent ([Figure 5](#fig5){ref-type="fig"}B). Although we could not detect phosphorylated forms of full-length Drf1 on normal SDS-PAGE gels (e.g., [Figure 5](#fig5){ref-type="fig"}B), we did observe phosphorylated forms of Drf1 in MBT-stage embryos using Phos-tag PAGE gels ([Figure 5](#fig5){ref-type="fig"}C). Together these experiments demonstrate that phosphorylated Drf1 is bound by β-Trcp at the MBT.Figure 5Chk1 Phosphorylates Drf1 for β-TRCP-Dependent Degradation(A and B) Western blots after immunoprecipitation (IP) of myc-tagged Drf1 or unrelated myc-tagged protein of the same size (Smicl) from MBT-stage extracts co-expressing HA-tagged β-TRCP. Asterisk denotes immunoglobulin heavy chain.(C) Anti-myc Western blot of myc-tagged Drf1 from MBT-stage embryos resolved on a phos-tag SDS-PAGE gel.(D) Anti-myc Western blot of myc-tagged Drf1 fragments expressed in embryos and harvested at the indicated times.(E) As in (D). For only the Chk1 blot from the over-expression of *chk1 D148A*, extracts were diluted 1 in 20 to allow a direct comparison between endogenous and over-expressed Chk1. All other western blots are of undiluted samples.(F) Scale diagram of *Xenopus laevis* Drf1, showing the three conserved Dbf4 domains (N, M, and C) and the degenerate potential β-TRCP binding domains (pink) within the region 1--467. Top: alignment of potential β-TRCP binding sites between *X. laevis* and *Xenopus tropicalis*. Asterisks denote residues mutated to alanine in the Drf1 6A mutant.(G and H) Left: immunoprecipitations as in (A). Right: western blot as in (D) and (E). WT, wild-type. Δ indicates Drf1 with both potential β-TRCP binding sites deleted. 6A denotes full-length Drf1 with the six residues marked by asterisks in (F) mutated to alanine.(I) As in (E).

β-Trcp binds substrates such as β-catenin through a characteristic interaction motif (DpSGΦXpS), where Φ represents a hydrophobic residue, X represents any amino acid, and pS represents phosphoserine ([@bib40]). We did not identify any perfect matches for this consensus sequence in *Xenopus* Drf1, so we expressed truncated forms of Drf1 to narrow down which regions might be required for β-Trcp binding and degradation. While a C-terminal fragment of Drf1 (453--784) remained stable, an N-terminal fragment (13--467) was degraded at the MBT like the full-length protein ([Figure 5](#fig5){ref-type="fig"}D). Importantly, this smaller N-terminal fragment of Drf1 exhibited a mobility shift from the MBT onward ([Figure 5](#fig5){ref-type="fig"}D). To test whether this modification was Chk1 dependent, we analyzed the Drf1-N terminal fragment with or without expression of the *chk1* dominant-negative mutant. While Drf1 modification and degradation was coincident with Chk1 activation in control embryos, the Chk1 D148A mutant prevented both the degradation and the appearance of lower-mobility forms of Drf1 ([Figure 5](#fig5){ref-type="fig"}E). We conclude from [Figures 5](#fig5){ref-type="fig"}D and 5E that Chk1-dependent phosphorylation and degron motifs are contained within the N-terminal region of Drf1.

Cdc25A, which is degraded in a Chk1 and β-Trcp-dependent manner in *Xenopus*, also lacks canonical β-Trcp interaction motifs ([@bib20]), so we searched the Drf1 N terminus for degenerate β-Trcp binding sites. We identified two motifs with the consensus DSX~3-5~S in the Drf1 region 13--467 ([Figure 5](#fig5){ref-type="fig"}F). To test the role of these motifs in β-Trcp interaction and degradation, we deleted them and expressed the mutated *drf1* mRNA in *Xenopus* embryos. While full-length Drf1 interacted with β-Trcp and was degraded as expected at the time of the MBT, Drf1 lacking both DSX~3-5~S motifs (Δ) did not interact with β-Trcp ([Figure 5](#fig5){ref-type="fig"}G, left) and was stable at the MBT ([Figure 5](#fig5){ref-type="fig"}G, right). In addition to this truncation mutant we also generated a mutant of *drf1* where several key residues within the DSX~3-5~S motifs (asterisk in [Figure 5](#fig5){ref-type="fig"}F) were mutated to alanine (6A). As with the mutant lacking both motifs, the Drf1 6A mutant did not bind to β-Trcp and was not degraded ([Figure 5](#fig5){ref-type="fig"}H). To address whether Drf1 6A could still be phosphorylated by Chk1, we analyzed the phospho-shift of the N-terminal fragment of the protein. As expected, the Drf1 6A 13--467 N-terminal fragment was not degraded at the MBT, and although this protein still exhibited some mobility shift coincident with Chk1 activation, the ratio of phospho-Drf1 to unmodified Drf1 was less than for the wild-type protein ([Figure 5](#fig5){ref-type="fig"}I). Together, [Figure 5](#fig5){ref-type="fig"} shows that Chk1 causes Drf1 phosphorylation and degradation, likely by generating a phospho-interaction between Drf1 and SCF^β-TRCP^.

Downregulation of Drf1 Is Important for Embryogenesis {#sec2.7}
-----------------------------------------------------

We have previously shown that only one replication factor needs to be limiting for the lengthening of the cell cycle at the MBT ([@bib5]). As a consequence, while inhibition of Drf1 can act as a failsafe to guarantee the lengthening of the cell cycle at the MBT (see [Discussion](#sec3){ref-type="sec"}), over-expression of Drf1 alone (or inhibition of Chk1 or SCF^β-TRCP^ alone) has little effect on the cell cycle during divisions 12--15 ([Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}; [@bib5]) because the other three factors (Treslin, Cut5, and Recq4) remain limiting. We therefore wondered whether there might be a role for Chk1-dependent downregulation of Drf1 in normal *Xenopus* development that is independent of cell-cycle control at the MBT.

Over-expression of Drf1 or the Drf1 6A mutant that is not degraded at the MBT ([Figure 5](#fig5){ref-type="fig"}) resulted in relatively normal development until gastrulation, at which point greater than 70% of embryos were still viable (stage 11, [Figure 6](#fig6){ref-type="fig"}A). However, these embryos exhibited a dramatic drop in viability during neurulation, and embryos expressing the Drf1 6A mutant failed to form neural folds (stage 20, [Figure 6](#fig6){ref-type="fig"}A). While a small fraction of Drf1 over-expressing embryos reached the tailbud stage (stage 32), none of the embryos expressing Drf1 6A were viable beyond this point in development ([Figure 6](#fig6){ref-type="fig"}A). These observations contrast dramatically with the over-expression of the Drf1 paralog Dbf4, whereby embryos remained fairly normal, with high viability during these embryonic stages ([Figure 6](#fig6){ref-type="fig"}A). This experiment shows that control of Drf1 levels, through Chk1- and SCF^β-TRCP^-dependent degradation, is important for early vertebrate development.Figure 6Inhibition of Drf1 Is Important for Development(A) Images of staged embryos, injected at the 1-cell stage with water (control) or mRNA (over-expression). Percentages underneath the images represent the number of embryos that survived beyond that stage. n = 50 embryos for each condition.(B) As in (A); 500 pg of *cdk1-AF* and 1 ng of *drf1* were injected at the 1-cell stage.

Inhibition of Chk1 through over-expression of the *chk1 D148A* dominant-negative mutant results in the onset of cell death and loss of viability during gastrulation, as previously described ([@bib37]). As the phenotype of Drf1 over-expression ([Figure 6](#fig6){ref-type="fig"}A) is less severe than the phenotype after over-expression of the *chk1 D148A* dominant-negative mutant, we hypothesized that Chk1 must have other functions apart from the downregulation of Drf1.

Although we did not detect any role for Chk1-mediated regulation of Cdk1 for cell-cycle control during the MBT ([Figure S5](#mmc1){ref-type="supplementary-material"}), we wondered whether both Drf1 downregulation and Cdk1 downregulation might be essential events during *Xenopus* embryogenesis. If this were the case we would expect deregulation of Drf1 and Cdk1 to have synergistic effects on viability during embryogenesis. While over-expression of *cdk1-AF* resulted in embryonic death during gastrulation at the end of stage 11, over-expression of both *drf1-6A* and *cdk1-AF* caused a more severe phenotype, with embryos dying at the blastula stage ([Figure 6](#fig6){ref-type="fig"}B). This shows that the regulation of both Drf1 and Cdk1 are important events during blastula-to-gastrula development in *X. laevis*.

Inhibition of Drf1 Is an Essential Function of Chk1 {#sec2.8}
---------------------------------------------------

Chk1 is essential for embryogenesis, as embryos expressing a dominant-negative mutant of *chk1* all die during gastrulation ([@bib37]). In addition, a mutant of Drf1 that is refractory to downregulation by Chk1 (Drf1-6A) is also lethal ([Figure 6](#fig6){ref-type="fig"}A). We hypothesized that if the downregulation of Drf1 is a critical function of Chk1, inhibition of Drf1 might at least partially rescue loss of Chk1 activity. To test this idea we downregulated Drf1 expression using *drf1* antisense morpholinos ([Figure 7](#fig7){ref-type="fig"}C). Partial inhibition of Drf1 affected embryonic development only slightly, while embryos expressing *chk1 D148A* all died at stage 11 ([Figure 7](#fig7){ref-type="fig"}A). Importantly, reducing Drf1 levels with an antisense morpholino partially rescued the embryonic death observed in the *chk1 D148A* mutant embryos, as these embryos survived until stage 12 ([Figure 7](#fig7){ref-type="fig"}A). We analyzed this rescue in detail by timing the onset of cell death in embryos after the MBT ([Figure 7](#fig7){ref-type="fig"}B). While over-expression of *chk1 D148A* resulted in cell death by stage 10.5, the *drf1* morpholino maintained viability in these embryos until entry into stage 12 ([Figure 7](#fig7){ref-type="fig"}B). This demonstrates that Drf1 inhibition is a critical function of Chk1 during early embryogenesis. Since *drf1* morpholinos can only partially rescue the loss of Chk1 function, other roles of Chk1 are likely to also be important during early embryogenesis, such as the regulation of Cdk1 ([Figure 6](#fig6){ref-type="fig"}B).Figure 7Inhibition of Drf1 Is a Crucial Function of Chk1(A) As for [Figures 6](#fig6){ref-type="fig"}A and 6B. The control was injection of a control morpholino (MO). n = 50 embryos for each condition.(B) Measurement of the appearance of cell death (white, extruded cells) from the start of stage 10 (9.5 hr post fertilization). n = 100 embryos for each condition.(C) Western blot from stage-11 embryo extracts showing the partial knockdown of Drf1 and Cdc6 after the morpholino (MO) injections.(D) The nuclear to cytoplasmic ratio ensures the lengthening of the cell cycle at the MBT both by out-titration of limiting replication factors (yellow box) and by inducing Chk1 activation, leading to Drf1 downregulation (red circle). See also [Figure S7](#mmc1){ref-type="supplementary-material"}. Inhibition of Drf1 is the primary mechanism by which Chk1 elongates the cell cycle in the early embryo. Chk1-dependent degradation of Drf1 ensures a switch to Dbf4 as the regulatory subunit of DDK in post-MBT cycles. Downregulation of Drf1 is critical for developmental processes from the blastula stage onwards. Stages 1--6 are excluded for simplicity.

Although Chk1 inhibition alone has no detectable effect on S-phase length or cell-cycle control during the MBT ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}), we wondered whether the *drf1* morpholino might rescue the *chk1 D148A* mutant phenotype because it partially inhibits DNA replication. To examine this we tested whether morpholinos against *cdc6* ([@bib5]), an upstream component in DNA replication control, could also suppress the phenotypes of *chk1 D148A*. Unlike the *drf1* morpholinos, partial inhibition of Cdc6 did not rescue the *chk1 D148A* phenotype ([Figure 7](#fig7){ref-type="fig"}A). From this we conclude that Chk1-dependent inhibition of Drf1 is essential during early development, but not through its role in controlling the rates of replication initiation (see [Discussion](#sec3){ref-type="sec"}).

Together, these data demonstrate that Chk1-dependent inhibition of Drf1 is an essential function of Chk1 during *Xenopus* embryogenesis and is the mechanism by which Chk1 regulates cell-cycle progression in the early embryo.

Discussion {#sec3}
==========

Ensuring Cell-Cycle Elongation at the MBT {#sec3.1}
-----------------------------------------

Proliferation control and cell-cycle remodeling are key features of embryonic development across organisms ([@bib4]). We have previously shown that changes in replication initiation and subsequently in S-phase length cause slowing of the cell cycle at the MBT during cycles 12--15 in *X. laevis* ([@bib5]). Four key limiting replication initiation factors---Drf1, Treslin, Recq4, and Cut5---govern the rate of replication initiation at this stage of development and their out-titration by the increasing N/C ratio acts as a timer for the elongation of the cell cycle at the MBT ([Figure 7](#fig7){ref-type="fig"}D). Despite this, how the precise amount of these proteins is regulated during early development is not known. Here we present a pathway that acts as a guarantee that the cell cycle elongates at the correct number of cell divisions ([Figure 7](#fig7){ref-type="fig"}D).

In addition to titrating key limiting replication factors ([@bib5]), the N/C ratio is important for the developmental activation of Chk1 in *X. laevis* ([@bib10]). We show here that a function of Chk1 at the MBT is to downregulate Drf1 through SCF^β-TRCP^-dependent degradation ([Figure 7](#fig7){ref-type="fig"}D). As limiting the amount of any one of Drf1, Treslin, Recq4, or Cut5 is sufficient to elongate the cell cycle at the MBT, by degrading Drf1 this pathway guarantees that the cell cycle lengthens from cycle 12 onward, regardless of the levels of the other three factors ([Figure 7](#fig7){ref-type="fig"}D). Therefore, the N/C ratio serves as a robust timed switch for embryonic cell-cycle control both through out-titration of limiting replication factors and through Chk1 activation ([Figure 7](#fig7){ref-type="fig"}D).

Notably, we observe a difference in the cell cycle at the MBT depending on whether Drf1 is over-expressed or stabilized (e.g., by inhibition of SCF^β-TRCP^). While over-expression of all four factors allows synchronous cleavages across cycles 12--15 ([Figure 1](#fig1){ref-type="fig"}), stabilization of Drf1 causes this protein to become limiting as early as cycle 13 ([Figure S7](#mmc1){ref-type="supplementary-material"}). We conclude from this that Drf1 is limiting both by Chk1-SCF^β-TRCP^-dependent degradation and by out-titration of this protein by the N/C ratio ([@bib5]). Together, these mechanisms ensure that the cell cycle elongates in a timely manner at the MBT ([Figure 7](#fig7){ref-type="fig"}D).

A remaining question is how the N/C ratio causes Chk1 activation at the MBT in *Xenopus*. Work in *Drosophila* has suggested that conflict between replication and early zygotic transcription is a trigger for checkpoint activation ([@bib2]), but it is unknown whether a similar mechanism exists in *Xenopus*. It is also unclear whether SCF^β-TRCP^ is regulated during early embryogenesis, as the level of this ligase is also an important determinant of cell-cycle elongation ([Figures 4](#fig4){ref-type="fig"} and [S6](#mmc1){ref-type="supplementary-material"}).

Chk1 Regulation of DDK {#sec3.2}
----------------------

Chk1 inhibits DNA replication both in cultured mammalian cells and in *Xenopus* egg extracts after replication stress and DNA damage ([@bib12], [@bib26], [@bib34]). We have previously shown in budding yeast that the checkpoint kinase Rad53 inhibits replication initiation in part by targeting Dbf4 ([@bib48]). In this study we show that it is the Dbf4 ortholog Drf1 that is downregulated in a Chk1-dependent manner ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [5](#fig5){ref-type="fig"}). DDK is clearly an important target of Chk1 in pre-MBT embryos because over-expression of either Dbf4 or Drf1 is sufficient to reverse the cell-cycle arrest caused by ectopic Chk1 over-expression ([Figure 3](#fig3){ref-type="fig"}). Since Drf1 and Dbf4 have equivalent roles in replication initiation ([@bib39], [@bib43]) and are both able to suppress the Chk1-mediated arrest, we think it is likely that Chk1 blocks cell-cycle progression by inhibiting replication initiation. The ability of Drf1 over-expression to suppress the cell-cycle arrest induced by Chk1 ([Figure 3](#fig3){ref-type="fig"}) explains how over-expression of Drf1 (together with the other limiting replication factors) permits fast cell cycles at the MBT despite earlier Chk1 activation ([Figure 1](#fig1){ref-type="fig"}A).

It is intriguing that Drf1 is replaced by Dbf4 as the regulatory subunit of DDK kinase at the MBT ([@bib39], [@bib43]). Our work suggests that the role of Chk1 in DNA replication control must also change after the MBT, when Drf1 is absent. It has been shown that Chk1 can bind to and inhibit Treslin to regulate replication initiation in human cells and *Xenopus* egg extracts ([@bib11]). Our data show that Chk1 activation in pre-MBT embryos can be fully suppressed by over-expression of Dbf4 ([Figure 3](#fig3){ref-type="fig"}), suggesting that Treslin, which is essential for replication initiation, is not inhibited under these circumstances. In addition, Treslin is still limiting for rapid cell-cycle progression at the MBT even if Chk1 is inhibited ([Figure S2](#mmc1){ref-type="supplementary-material"}). Although this suggests that Chk1 does not inhibit Treslin during embryogenesis, it does not preclude this as a mechanism for Chk1-dependent replication control, for example in somatic cells.

Chk1 Regulation of Cdk1 {#sec3.3}
-----------------------

A well-established role of Chk1 both in the response to DNA damage ([@bib1]) and also during the MBT in *Drosophila* is to inhibit Cdk1 by either activating Wee1 or inhibiting Cdc25 ([@bib47]). Importantly, regulation of Cdk1 by Chk1 does not cause significant changes in cell cycles 12--15 in *Xenopus* either from the analysis of Cdc25 mutants ([@bib37]) or from over-expression of an uninhibitable form of Cdk1 (*cdk1-AF*, [Figure S5](#mmc1){ref-type="supplementary-material"}). In addition, inhibition of Wee1/Myt1 has little effect on cell-cycle duration in pre-MBT cycles ([@bib45]). Cdk1 regulation by Chk1 is also not a significant mechanism for cell-cycle arrest following ectopic expression of Chk1 in *Xenopus* embryos, because this is rescued solely by expression of Dbf4 or Drf1 ([Figure 3](#fig3){ref-type="fig"}) and not by the *cdk1-AF* allele ([Figure S4](#mmc1){ref-type="supplementary-material"}).

Our data suggest that cell-cycle elongation at the MBT in *Xenopus* is controlled by changes in S-phase length throughout-titration and Chk1-dependent degradation of limiting replication factors ([Figure 7](#fig7){ref-type="fig"}D). This, however, does not exclude an important role for Cdk1 regulation from cycle 15 onward, and over-expression of the *cdk1-AF* mutant is indeed lethal after stage 11 ([Figure 6](#fig6){ref-type="fig"}). It is also striking that *Xenopus* Cdc25 regulation by Chk1 mirrors that of Drf1 ([Figure 5](#fig5){ref-type="fig"}), as Cdc25 is also inhibited by Chk1-dependent, SCF^β-TRCP^-mediated degradation ([@bib46]).

In *Drosophila* embryos, gradual changes in S-phase length in cycles 10--13 precede dramatic downregulation of Cdc25 (string and twine) in part caused by Chk1 (grapes) activation, resulting in even greater extension of S phase and the introduction of G~2~ phase in cycle 14 ([@bib6], [@bib7]). Although extension of S phase is the initial cause of cell-cycle lengthening in both flies and frogs ([@bib5], [@bib36]), a significant difference is that inhibition of Chk1 (grapes) in *Drosophila* is sufficient to shorten the cell cycle during the MBT cycles 11--13 ([@bib38]), which is not the case during the MBT cycles 12--15 in *Xenopus* ([Figure 1](#fig1){ref-type="fig"}). Further understanding of the functions of Chk1 in different organisms may help to explain such differences in embryonic cell-cycle control.

Drf1 Downregulation Is an Essential Function of Chk1 {#sec3.4}
----------------------------------------------------

Chk1 is an essential enzyme during normal development in many metazoa ([@bib9], [@bib18], [@bib25], [@bib37], [@bib44]). Indeed, inhibition of Chk1 leads to embryonic death during gastrulation in *X. laevis* ([Figure 7](#fig7){ref-type="fig"}A; [@bib37]). We show here that downregulation of Drf1 is a critical function of Chk1 during early embryogenesis ([Figure 6](#fig6){ref-type="fig"}) and that inhibition of Drf1 partially rescues the *chk1 D148A* mutant phenotype ([Figure 7](#fig7){ref-type="fig"}). Since *drf1* morpholinos can only partially rescue the loss of Chk1, it is likely that Chk1 has other important functions during embryogenesis such as the regulation of Cdc25. Indeed the *cdk1-AF* mutant, which cannot be regulated by the Wee1/Cdc25 axis, shows synergistic lethality with *drf1-6A* ([Figure 6](#fig6){ref-type="fig"}B).

In normal embryos, Chk1 activation ensures that Drf1 is replaced by its paralog Dbf4 after the MBT ([Figure 2](#fig2){ref-type="fig"}; [@bib39], [@bib43]). An important remaining question is why degradation of Drf1 is so important for the blastula to gastrula stage of development. Both Drf1 and Dbf4 have equivalent roles in replication initiation ([@bib39], [@bib43]) and are both capable of driving replication initiation in MBT-stage embryos (data not shown). Several lines of evidence suggest that the essential role of Drf1 downregulation might not be due to shared functions with Dbf4 in replication initiation control. First, Drf1 over-expression alone, which is not sufficient to induce high replication initiation rates ([@bib5]), is by itself lethal during early embryogenesis, whereas Dbf4 over-expression is not ([Figure 6](#fig6){ref-type="fig"}A). In addition, although downregulation of Drf1 partially rescues the Chk1 dominant-negative phenotype, inhibition of Cdc6, an upstream component of replication initiation, has no effect ([Figure 7](#fig7){ref-type="fig"}A). Therefore, while Drf1 downregulation by Chk1 acts as a guarantee that the cell cycle lengthens at the MBT, there must also be additional functions for a handover between Drf1 and Dbf4 at this stage in development ([Figure 7](#fig7){ref-type="fig"}D).

Although we cannot rule out the possibility that there are subtle consequences for cell division if Drf1 levels are high during the MBT, we hypothesize that Drf1 and Dbf4 may have functions beyond DNA replication that must be correctly timed during embryogenesis. Such functions would explain why Drf1 and Dbf4, although equivalent in their role in replication initiation, have such different expression patterns and regulation during embryogenesis (this study; [@bib39], [@bib43]). Interestingly, Dbf4 has been suggested to be an inhibitor of Wnt-driven transcription ([@bib3]), which is switched on at the MBT in *Xenopus* ([@bib14]). This may not be a unique feature of Dbf4, however, because we observe similar phenotypes with Drf1, such as embryo ventralization after over-expression (e.g., [Figure 6](#fig6){ref-type="fig"}A). To understand the physiological roles of the Chk1-dependent switch from Drf1 to Dbf4 at the MBT, it will be important to further investigate the different functions of these proteins during embryogenesis.

Both Drf1 and Dbf4 orthologs exist in humans ([@bib27]), and Cdc7 kinase is emerging as a potential target in certain cancers ([@bib16]). In addition, Chk1 inhibitors are currently in clinical trials as chemotherapeutics ([@bib35]). Understanding the different functions of Drf1 and Dbf4, together with their interplay with Chk1 in vertebrates, may have significant implications for the use and effectiveness of drugs that target these proteins in humans.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Polyclonal rabbit anti-Drf1 antibodyGift from Tatsuro Takahashi (Osaka University) and Johannes Walter (Harvard Medical School)([@bib43])Polyclonal rabbit anti-Dbf4 antibodyGift from Tatsuro Takahashi (Osaka University) and Johannes Walter (Harvard Medical School)([@bib43])Mouse monoclonal anti-Myc antibody (lyophilized) and dissolved in water to a concentration of 1 mg/mlRoche(cat \# 11667149001)Mouse monoclonal anti-HA antibodyOrigene(cat \# TA180128)Mouse monoclonal anti-Chk1 antibody (DCS-310)Thermo Scientific(cat \# MA1-91087)Rabbit polyclonal anti-βTrcpAbcam(ab137674)Mouse monoclonal anti-Myc antibody (9E10) coated magnetic beadsOrigene(cat \# TA150044)**Biological Samples***Xenopus laevis* embryosNASCON/A**Chemicals, Peptides, and Recombinant Proteins**Phos-tag acrylamideAlpha Laboratories Ltd(cat \#304-93521)Trizol reagentInvitrogen(cat \#15596-026)**Critical Commercial Assays**Transcriptor First Strand cDNA kitRoche(cat \#04379012001)mMESSAGE mMACHINE SP6 Transcription KitThermoFisher ScientificAM1340AphidicolinSigmaCat 0781**Experimental Models: Organisms/Strains***Xenopus laevis* WTNASCON/A**Oligonucleotides**Morpholino\
*cdc6A*MO:\
5'-CTGGTGCTTGGCATGGCTGCTTGTC-3'\
*cdc6B*MO:\
5'-AATTCAGTCAGAAATAACCAGGCTC-3'([@bib5])\
Gene ToolsN/A*drf1*MO:\
5'-GCAGAACAGAGATCACACTGGCCAT-3'([@bib5])\
Gene ToolsN/A*βtrcp*MO:\
5'-GAGAACATGAAAATCCTTCCATCTC-3'This paper\
Gene ToolsN/A*dbf4*MO:\
5′-CACTGCTGCTATGGTAGATTTCATT-3′Described in ([@bib3]) as XDMO1\
Gene ToolsN/AcoMO:\
5\'-CCTCTTACCTCAGTTACAATTTATA 3\'Standard control morpholino from Gene ToolsN/A**Recombinant DNA***Xenopus laevis chk1* in pCS2This paperN/A*Xenopus laevis chk1 D148A* in pCS2This paperN/A*Xenopus laevis β-trcp* in pCS2 with N-terminal HA tagThis paperN/A*Xenopus laevis dbf4* in PCS2This paperN/A*Xenopus laevis drf1* (Drf1) with N-terminal 6xMyc tag in PCS2This paperN/A*Xenopus laevis drf1* (Drf1-N) with N-terminal 6xMyc tag in pCS2This paperN/A*Xenopus laevis drf1* with 6 amino acid substitutions (Drf1 6A) with N-terminal 6xMyc tag in pCS2This paperN/A*Xenopus laevis drf1* (13-467) with 6 amino acid substitutions and N-terminal 6xMyc tag in pCS2 (Drf1 6A)This paperN/A*Xenopus laevis cdk1* in pCS2 with N-terminal HA tagThis paperN/A*Xenopus laevis cdk1AF* in pCS2 with N-terminal HA tag([@bib33])N/A*Xenopus laevis drf1* lacking amino acids 165-174 and amino acids 455-467 (Drf1 Δ) with N-terminal 6xMyc tag in pCS2This paperN/A*Xenopus laevis treslin* in pCS2 with C-terminal Flag tag([@bib5])N/A*Xenopus laevis recq4* in pCS2([@bib5])N/A*Xenopus laevis drf1* in pCITE4aGift from Tatsuro Takahashi (Osaka University, Japan)([@bib5])N/A*Xenopus laevis cut5* in pCS2Gift from Haruhiko Takisawa (Osaka University, Japan)N/A**Software and Algorithms**FijiN/AN/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Philip Zegerman (<paz20@cam.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### *Xenopus laevis* Induction and Husbandry {#sec4.3.1}

Regulations for the use of *Xenopus laevis*, as outlined in the Animals Scientific Procedures Act (ASPA) and implemented by the Home Office in the UK, were followed.

Frogs were obtained from NASCO and kept in a *Xenopus* research facility designed by Aqua Schwarz. Tanks contained dechlorinated water at 19°C, pH 7.5 and conductivity between 900-1100 μS/cm. Ammonia and nitrite levels were at 0 ppm. The light/dark cycle in the room was 12h/12h. Tanks were populated with 3 females or 6 males. Frogs were fed a diet of 3 x 1 g of 5LP3 frog diet advanced protocol (from labdiet), per frog and per week.

Females were induced by injection of 400 U Chorulon (Human Chorionic Gonadotrophin), followed by injection of 50 U PMSG (Pregnant Mare's Serum Gonadotrophin) from Intervet within 10 to 12 days. Males were killed by injection of an overdose (160 mg) of the anesthetic MS222 dissolved in water.

Adult males and females were only used to obtain sperm and eggs respectively.

All experiments were performed on embryos.

### *Xenopus laevis* Embryo Culture and Injections {#sec4.3.2}

Embryos of *Xenopus laevis* were obtained by artificial fertilisation. They were maintained in 10% normal amphibian medium (NAM) (100 mM NaCl, 2 mM KCl, 1 mM Ca(NO~3~)~2~.4H~2~O, 1 mM MgSO~4~.7H2O, 0.1mMEDTA, 0.02 mM NaH~2~PO~4~.2H2O, 0.08 mM Na~2~HPO~4~.2H~2~O) ([@bib41]) at 20 °C and staged ([@bib32]). *Xenopus* embryos were injected at the one or two cell stage (as indicated in the figure legends) with antisense morpholino oligonucleotides (MOs) (dissolved in water) obtained from GeneTools, LLC or with sense RNA obtained by in vitro transcription (as indicated in the figure legends).

Method Details {#sec4.4}
--------------

### Cloning and *In Vitro* Transcription {#sec4.4.1}

Total RNA was isolated from *Xenopus* embryos using the TriPure reagent (Invitrogen), followed by a LiCl precipitation. cDNA was prepared by reverse transcription, using the Transcriptor First Strand cDNA kit (Roche).

The coding sequence of *Xenopus laevis chk1* was amplified by PCR and cloned between the EcoRI and XhoI sites of pCS2. cDNA encoding a dominant negative Asp148 to Ala mutant (Chk1D148A, [@bib28]), was cloned between the EcoRI and XhoI sites of pCS2. The coding sequence of *Xenopus laevis β-trcp* was amplified by PCR and cloned in frame with an N-terminal HA tag between the ClaI and XhoI sites of pCS2.

The coding sequence of *Xenopus laevis dbf4* was amplified by PCR and cloned between the EcoRI and XhoI sites of pCS2. Drf1 full length and N and C truncations were amplified by PCR and cloned between the EcoRI and XhoI sites of Myc-pCS2. Drf1 Δ corresponds to *drf1* lacking amino acids 165-174 and amino acids 455-467. cDNA encoding *drf1* with 6 amino acid substitutions to alanine (Drf1 6A) at the following positions (Asp169, Ser170, Thr171, Ser174, Ser466 and Thr467) was cloned between the EcoRI and XhoI sites of Myc-pCS2. The coding sequence of *Xenopus laevis cdk1* (Cdk1) and Cdk1AF (T15A, Y16F - [@bib33]) were amplified by PCR and cloned in frame with an N-terminal HA tag. Amino acids 215-474 of *Xenopus laevis Chk1* (Myc-Chk1ΔKD) was amplified by PCR and cloned between the EcoRI and XhoI sites of Myc-pCS2.

To obtain sense RNA from these constructs, plasmids were digested with Not1 followed by in vitro transcription using SP6 RNA polymerase.

To obtain sense RNA, *treslin*, *cut5*, *drf1* and *recq4* containing plasmids (described in ([@bib5])) were digested respectively with Not1, Asp718, SpeI and Asp718. SP6 RNA polymerase was used for in vitro transcription of *treslin*, *cut5* and *recq4* and T7 polymerase for *drf1*.

### Western Blotting {#sec4.4.2}

Anti-Drf1 and anti-Dbf4 were used at concentrations of 1/10000 and 1/3000 respectively in PBS with 0.1% Tween and incubated overnight. at 4°C. Anti-HA, anti-Myc and anti-βTrcp were used at a concentration of 1/1000 in PBS+0.1%Tween and incubated 1 hr at room temperature. Anti-Chk1 was used at a concentration of 1/100 in PBS+0.1%Tween and incubated 1 hr at RT. Goat anti-rabbit (Thermo Scientific 31466) and horse anti-mouse (Vector Laboratories PI 2000) HRP coupled antibodies were used as secondary antibodies and used at concentrations of 1/10000 in PBS+0.1%Tween and incubated for 1 hour at room temperature.

### Co-Immunoprecipitation Experiments {#sec4.4.3}

*Xenopus* embryos were frozen in liquid nitrogen and solubilised in lysis buffer containing 1% NP40, 150 mM NaCl, 20 mM Tris pH 7.5, 2 mM EDTA, 50 mM NaF, 1 mM sodium pyrophosphate, supplemented with protease inhibitors (Roche). Yolk and lipids were extracted with Freon and lysates were cleared by centrifugation. Precipitations were performed by overnight incubations with mouse monoclonal anti-Myc coated magnetic beads at 4°C. Unbound proteins were removed by washing four times with lysis buffer and once with phosphate-buffered saline at 4°C. Bound proteins were harvested by boiling in sample buffer, and they were resolved by SDS-polyacrylamide gel electrophoresis.

### Phostag Gel Electrophoresis {#sec4.4.4}

*Xenopus* embryos were frozen in liquid nitrogen and solubilised in lysis buffer containing 1% NP40, 150 mM NaCl, 20 mM Tris pH 7.5 and 2 mM EDTA, supplemented with protease inhibitors (Roche). Yolk and lipids were extracted with Freon and lysates were cleared by centrifugation. Proteins were precipitated with trichloroacetic acid (final concentration 12.5%). After washing the pellet in ice-cold acetone, proteins were dissolved in 1x restriction enzyme buffer 3 from NEB. MnCl~2~ was added to a final concentration of 0.066 mM. Proteins were then resolved by SDS polyacrylamide gel electrophoresis with resolving gel -- 4% acrylamide, acrylamide/bisacrylamide = 29/1, 0.5% agarose, 0.035 mM MnCl~2~, 375 mM Tris pH 8.8, 0.1% SDS, 0.001 % Temed, 0.05% APS, 0.0125 mM Phos-tag acrylamide (Alpha Laboratories Ltd) and stacking gel -- 3% acrylamide, acrylamide/bisacrylamide = 29/1, 125 mM Tris pH 6.8, 0.001% Temed, 0.05% APS. The gel was incubated 3 X 15 min in 10 mM EDTA before Western blotting.

### Preparation of Bulk Genomic DNA {#sec4.4.5}

*Xenopus* embryos were dissolved in lysis buffer (150 mM NaCl, 10 mM EDTA, 50 mM Tris pH 7.5, 0.5 % SDS) and treated with RNAse A for 2 hours at 37°C (final concentration 20 μg/ml) and then overnight with proteinase K at 55°C (final concentration 0.25 mg/ml). After phenol/chloroform extraction and ethanol precipitation of the sample, DNA pellets were dissolved in H~2~O and loaded onto a 1% agarose gel.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Movies {#sec4.5.1}

Movies were made with a Leica MZ FL III microscope at 20°C and analysed with ImageJ (Fiji) software. Numbers of cells and embryos analysed are indicated in the figure legends.

Numbers of embryos injected for phenotypical analysis are indicated in the figures and figure legends.

The quantification of bulk genomic DNA was performed on three biological replicates and the intensity of the bands was scanned and analysed with ImageJ software.
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Supplemental Information {#app2}
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Document S1. Figures S1--S7Movie S1. Chk1 Inhibition Does Not Affect the Cell Cycles at the MBT, Related to Figure 1The top 4 embryos were control (water) injected, the 2 embryos below that were injected with *chk1 D148A* mRNA and the bottom 2 embryos were injected with mRNA for *cut5, drf1, treslin* and *recq4.*Movie S2. Chk1 Inhibits Drf1 at the MBT, Related to Figure 2The top 3 embryos were control (water) injected, the 3 embryos below that were injected with *chk1 D148A* mRNA, the 3 embryos below that were injected with mRNA for *cut5, treslin* and *recq4* and the bottom 3 embryos were injected with mRNA for *cut5, treslin* and *recq4* and *chk1 D148A.*Movie S3. Over-expression of Treslin, Recq4, and Cut5 Is Required for Rapid Cell Divisions at the MBT in Embryos Expressing Chk1 D148A, Related to Figure S2The embryo in the top right was control (water) injected, the 2 embryos top/centre were injected with mRNA for *chk1 D148A, treslin* and *recq4*, the 2 embryos below that were injected with mRNA for *chk1 D148A, treslin* and *cut5*, the 2 embryos below that were injected with mRNA for *chk1 D148A, recq4* and *cut5* and the bottom 2 embryos were injected with mRNA for *cut5, treslin* and *recq4* and *chk1 D148A.*Movie S4. β-TRCP Controls Drf1 Levels, Related to Figure 4The top 2 were injected with control morpholino, the 2 central embryos were injected with the anti *β-trcp* morpholino and the bottom 2 embryos were injected with the anti *β-trcp* morpholino plus mRNA for *cut5, treslin* and *recq4.*Movie S5. Chk1 Blocks the Cell Cycle by Inhibiting DDK, Related to Figure 3The top 3 embryos were injected with *chk1* mRNA(50 pg), the middle 3 with *chk1* (50 pg) + *drf1* (500 pg) and the bottom 3 with *chk1* (50 pg) + *dbf4* (500 pg).Document S2. Article plus Supplemental Information
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